North Carolina

Go Back to Map ←

North Carolina’s bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.

Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.

Total Number of Facilities in North Carolina 64
Jobs Directly Supported by the Industry in North Carolina 92223
Annual Average Wage
Total Clinical Trials
Dollar Amount Invested in Clinical Trials
$648.6 Million
Clinical Trial Participants
Total Clinical Trial Economic Impact
$1.8 Billion

View Facilities By District

District Total Facilities in District View Facilities in District
NC01 5 BASF Corp (A)

Cargill, Incorporated (A)

Domtar (A)


Purdue Pharma LP (H)

NC02 13 9 Meters Biopharma, Inc. (H)

Adrenas Therapeutics (H)

BASF Corp (A)

Domtar (A)

ElectriCities of North Carolina, Inc. (O)

FUJIFILM Diosynth Biotechnologies (H)

GlaxoSmithKline plc (H)

Inspire Pharmaceuticals, Inc (H)

Novozymes (A) (2)

OakLife Ai Biopharma, Inc (H)

PharmaDirections, Inc. (O)

UCB Biosciences, Inc (H)

NC03 1 Bayer (H)
NC04 32 Asklepios BioPharmaceutical, Inc. (AskBio) (H)

Bamboo Therapeutics, Inc. (H)

BASF Plant Science LP (A)

Bayer CropScience, Inc. (A)

Biogen Inc. (H) (2)

bluebird bio (H) (2)

Citranvi Biosciences LLC (H)

Curie Co. Inc. (H)

DMC Biotechnologies Inc. (A)

Ercole Biotech, Inc (H)

Heat Biologics, Inc (H)

Kowa Company, Ltd. (H)

Lamassu Pharma, LLC (H)

Leaf (A)

Medicago USA Inc. (H)

Mycovia Pharmaceuticals, Inc. (H)

NC Biosciences Organization (O)

North Carolina Biosciences Organization (O)

North Carolina Biotechnology Center (O)

Novozymes (A)

Pappas Capital, LLC (O)

Pappas Ventures (O)

PMP Public Affairs Consulting (O)

Precision BioSciences (H)

Purdue Pharma LP (H)

Scioderm, Inc. (H)

TheraVida, Inc (H)

Triangle Pharmaceuticals, Inc (H)

Vestaron Corporation (A)

Viiv Healthcare (H)

NC06 1 Novartis Animal Health US, Inc (A)
NC07 2 Amyris (A)

Cygnus Technologies, Inc (H)

NC08 1 Cargill, Incorporated (A)
NC11 1 Phytonix (A)
NC13 4 Chiesi USA, Inc. (H)

Grifols Therapeutics LLC (H)

Novo Nordisk Inc. (H)

Novo Nordisk Pharmaceutical Industries, Inc. (H)

NC14 4 BASF Corp (A)


Johnson & Johnson Health Care Systems Inc. (H)

Milestone Pharmaceuticals Inc. (H)